Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma

doi:10.3748/wjg.v17.i12.1631

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5052)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

403

HTML

4442

Figures (1-6)

110

Tables (1-4)

Sum=5052

Mar 28, 2011 (publication date) through Jan 4, 2025

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 28, 2011; 17(12): 1631-1641
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631

Full Size Figure Download Figure

Figure 3 Immunohistochemical examinations of trefoil factor proteins in cholangiocarcinoma (Original magnification × 400). A: Trefoil factor (TFF)1 staining was markedly positive and was mostly seen in the cytoplasm; B: TFF2 staining was mostly in the cytoplasm and at the invasion front (arrows); C: TFF3 staining showing a goblet cell pattern manifested as diffusely distributed coarse granules.

Citation: Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B, Limpaiboon T. Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 2011; 17(12): 1631-1641
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1631.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1631